47 results
Page 2 of 3
8-K
EX-99.1
cbl93fj46h h7qww
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
DEF 14A
vgyhcfnpnhj4lip48 r4
28 Apr 23
Definitive proxy
8:34am
10-Q
3k53pma
14 Nov 22
Quarterly report
4:46pm
424B4
6o3ir75s
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
errfcux73t4d2dmh
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-10.22
x0c04
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.17
v1rfj8l98t5c2erq3
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
rvlxn2 qw4b2gm81
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
1oep81mr
23 Sep 22
IPO registration
4:12pm
S-1
poogcmtmfs2xsrw62
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.18
auukjl
23 Sep 22
IPO registration
4:12pm
DRS/A
7wvff2hj
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
i7fc5eowtrlkv
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
dc2vzel
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
9q5881
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
x0247g0626
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
matpozbpa7
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.20
1vc aewjc
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
8s6cvl0hw8mjt6d2 xsc
7 Mar 22
Draft registration statement (amended)
12:00am